Non-Melanoma Skin Cancers Coverage from Every Angle
Editor:
Karl D. Lewis, MD
Advertisement
Advertisement

Recent News

Sequential Treatment Approach to Cutaneous Squamous Cell and Basal Cell Carcinomas: Case Report
Postoperative Radiotherapy for Merkel Cell Carcinoma: Survival and Recurrence
Use of Cemiplimab in Elderly, Frail Patients With Cutaneous Squamous Cell Carcinoma
Merkel Cell Carcinoma: Population-Based Study Focuses on Predictors of Relapse
Large French Study Explores the Use of Statins and Risk of Skin Cancer in Women
Is Eye Color a Predictor of Skin Cancer?
Impact of Sonidegib Dose Reductions and Interruptions in Patients With Advanced Basal Cell Carcinoma
Long-Term Survival Update From JAVELIN Merkel 200 With Avelumab in Metastatic Disease
SITC 2021: How Genetic Reprogramming of Merkel Cell Carcinoma May Impact MHC-I Expression and Immune Response
SITC 2021: T Antigen–Specific T Cells and Checkpoint Inhibition in Merkel Cell Carcinoma
SITC 2021: Phase II Study Results of Retifanlimab in Advanced Merkel Cell Carcinoma
Exposure to Ruxolitinib and Risk of Skin Cancer: Is There a Connection?
Racial Differences in Mohs Micrographic Surgery Defect Size: Does Size Matter?
Novel Optical Technology May Improve Evaluation of Treatment Response of Basal Cell Carcinomas
Electronic Brachytherapy for Basal Cell or Squamous Cell Carcinoma
Impact of Surgical Delays on Tumor Growth in Patients With Squamous Cell Carcinoma
Diagnostic Insights: Tumor Size and Dermoscopic Features of Basal Cell Carcinomas
Recognizing DNA Methylation Patterns and Their Functionality in Merkel Cell Carcinoma
Can Smartphone Images Improve on Dermoscopy for Diagnosis of Skin Cancer?
KEYNOTE-629: Use of Pembrolizumab in Treatment of Cutaneous Squamous Cell Carcinoma
Role of Sentinel Lymph Node Biopsy Status in Adjuvant Radiotherapy for Merkel Cell Carcinoma
ESMO 2021: Predictive Factors of Relapse in Cutaneous Squamous Cell Carcinoma
Predicting Response to Vismodegib in Locally Advanced Basal Cell Carcinoma
ESMO 2021: Final Results of Phase II Trial of First-Line Nivolumab in Squamous Cell Carcinoma
ESMO 2021: Extended-Dose Cemiplimab-rwlc Under Study in Squamous Cell Carcinoma
Topical Remetinostat Under Study in Basal Cell Carcinoma
Intraoperative Fluorescent Imaging Agent Under Study in Patients With Skin Cancer
Link Between Cutaneous HPV and Squamous Cell Skin Cancer?
Combination Checkpoint Antibody Treatment in Cutaneous Squamous Cell Carcinoma
Study Finds Stem Cell Markers Point to Origin and Prognosis in Merkel Cell Carcinoma
Does Lifetime Ambient UV Radiation Exposure Impact Skin Cancer Risk by Anatomic Site?
Is High Citrus Consumption Associated With Non-Melanoma Skin Cancer Risk?
Exclusive Radiotherapy: Potential Alternative to Surgery for Merkel Cell Carcinoma?
Use of Avelumab for Oligoprogression in Advanced Merkel Cell Carcinoma: Case Report
Checking Checkpoint Inhibitor Effectiveness in Immunocompromised Patients With Advanced Skin Cancer
Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.